New Approaches to Cancer Treatments Panel | 2024 NFCR Global Summit & Award Ceremonies

Explore cutting-edge advancements in cancer treatment with this insightful panel from the 2024 NFCR Global Summit and Award Ceremonies. Moderated by Dr. Lisa Coussens of Oregon Health & Science University, this session brings together renowned experts to discuss emerging therapies and the importance of personalized approaches in cancer care. Each panelist shares pioneering research and strategies that are reshaping the oncology landscape.

Panelists & Topics:
• Dr. Aditya Bardia (UCLA): Explores Antibody-Drug Conjugates (ADCs) for HER2-positive breast cancer, a breakthrough approach aiming to reduce chemotherapy toxicity.
• Dr. Jonathan Chernoff (Fox Chase Cancer Center): Discusses molecular glues for targeting “undruggable” proteins, particularly in RAS-driven cancers.
• Dr. Paul Mischel (Stanford University): Presents on extra-chromosomal DNA (ecDNA) and its role in treatment resistance, showcasing AI-driven research in glioblastoma and other aggressive cancers.
• Dr. Scott Lippman (UC San Diego): Talks about cancer interception and early detection using cell-free DNA (cfDNA) and how machine learning is driving precision medicine.

With a focus on actionable steps to advance research and develop new treatment strategies, this panel provides a glimpse into the future of oncology and the innovative approaches shaping patient care.

#Cancer #Research #NewCancerTreatments #CancerResearch #BeatCancer #CureCancer #howto